show that we have been sidetracked from our principal aim because of a series of observations which suggest that naturally-occurring protective mechanisms are much more prevalent in the horse than in man.
Man
It is known that immunization of the Rh-negative woman usually occurs as the result of a fetomaternal haemorrhage (FMH) at or near delivery, and that the size of the FMH can be readily assessed by the Kleihauer test, which demonstrates any cells containing fetal haemoglobin (Kleihauer et al. 1957 , Zipursky et al. 1959 , see Finn et al. 1961 ). The first Rhpositive baby is usually normal, but it is often the 'immunizing fetus', and Rhesus antibodies (principally 7S and never naturally-occurring) are formed in the succeeding weeks or months so that subsequent Rh-positive babies may be affected, since the antibodies cross the placenta and are the usual cause of erythroblastosis fetalis. The most important protective mechanism against Rhesus immunization is ABO incompatibility as between mother and fetus, e.g. Rhnegative group a mother and Rh-positive group A fetus, the mechanism here being that the naturally-occurring anti-A (or anti-B if the fetus is B) destroys the fetal cells in the maternal circulation before they have time to immunize the mother against the Rhesus antigen. The protective combination is only present, however, in 20% of cases, there being ABO compatibility between mother and fetus in 80% of cases.
An important point is that the anti-A or anti-B probably need only have a very weak titre in order to protect, since in hypogammaglobulinaemia, where the production of antibody is greatly reduced, ABO-incompatible cells are removed experimentally in a few hours (see Mollison 1972) .
Where a Rh-negative mother is compatible with her fetus on the ABO system, fetal cells survive normally, but they can be speedily removed by injecting anti-D gammaglobulin and immunization of the mother is thereby usually prevented (see . The early experiments which established this were carried out in Rh-negative male volunteers who were injected with chromium-51 labelled Rh-positive ABO compatible cells. There is now suggestive evidence that the anti-D is nonspecific, because anti-Kell has been shown to protect against D-sensitization, and the probable explanation of this is that coating of one antigen site renders the whole red cell non-antigenic (Woodrow et al. 1975 ). If the same principle held in the horse there would be important implications, because there is sometimes a naturally-occurring antibody to one of the principal antigens which cause haemolytic disease of the foal.
The horse
As in man, the first foal is not usually affected, and the assumption is that the mare too is immunized by an FMH, though this has not been demonstrated! and, because no staining differences have been detected between fetal and adult haemoglobin, the Kleihauer technique is useless. Again, as in man, immune antibodies are formed by the mare, but they reach the foal by way of the colostrum and not by crossing the placenta. The colostrum is highly toxic to the foal, but after about 36 hours, because of metaplasia in the gut epithelium, the antibody is no longer absorbed (see Roberts 1957) .
HDNF is not of great practical importance, because if it is known that the mare is immunized her teats can be covered or the foal muzzled and colostrum given from a nonimmunized mare. While the disease is never common, it is most prevalent in Thoroughbreds, less so in Shire horses and Arabs, and records of it having occurred in ponies are only Sporadic (A M Scott, 1977, personal communication) .
Current studies
By analogy with our experiments in man, we first injected 10-20 ml chromium-51 labelled red cells into nonimmunized ponies in which no antibodies were demonstrable by routine crossmatching, and the experiment was controlled by also injecting the ponies' own chromium-51 labelled red cells. The results were very different from those in man (see Gimlette, p 576), the allogeneic cells always (on 12 separate occasions) being largely eliminated (probably mainly to the spleen) within a matter of hours, whereas the autologous cells persisted much longer.
These initial findings have to be related to the fact that there is no need to cross-match before giving a horse a first blood transfusion, and any available animal can be used (Archer & Franks 1961) . The reason for this is that naturally-occurring antibodies are 'very weak, very rare and seem to have no effect on transfusion' (Archer & Franks 1961) . Though this explanation is clearly true for a transfusion, it may not hold for small quantities of blood such as presumably Usually occur in FMH, and we think that the rapid elimination of the small quantities of cells We gave is probably due to the presence of naturally-occurring antibodies, detectable by special methods but not by routine cross-matching. Thus, in Liverpool, we tested the neat serum of 17 ponies against a panel of cells obtained from 6 other ponies. The tests were made in saline at 10°C, and a 2% suspension of sodium chloride obviated roule~ux formation. The serum of only 3 ponies agglutinated none of the cells, and most sera agglutmated all the cells.
It is also of interest that we failed to immunize 6 of the ponies which had naturally-occurring antibody when 10-20 ml of blood was given intravenously, though immunization did occur on one occasion when a larger volume (40 ml) was injected intramuscularly, and it may be that naturally-occurring antibodies are absent from the tissue fluids.
To test the 'big volume versus small volume' hypothesis, we gave 400 ml of unlabelled blood with 10 mllabelled cells to see whether naturally-occurring antibodies would be 'swamped' and the chromium-51 labelled cells therefore survive much longer. Some support for this view was obtained (see Gimlette, p 576). If valid, it would be interesting to find out in man, by in vitro experiments, whether using a larger volume of incompatible blood diminishes the rate of destruction of the red cells, as it appears to do in the horse.
Our tentative suggestion is that naturally-occurring antibodies are protective in the pony against small FMHs and that this is why the disease is rare. It remains to be discovered whether the prevalence of the naturally-occurring antibodies is different in different breeds of horse, and if this is why the incidence of the disease varies.
There are some difficulties, however, about our hypothesis, as can be seen in the paper by Scott (p 581), where the gene frequencies of the common antigens responsible for HDNF are set out, as well as some of the specificities of the naturally-occurring antibodies. Furthermore, the rapid elimination of the chromium-51 labelled cells still occurs when it has been thought that no antibodies are present, but very weak ones may be difficult to detect even when testing at varying temperatures and altering the ratio of plasma to cells.
Transfusion of autologous and allogeneic chromium-51 labelled red cells in ponies The Liverpool Clinic, Myrtle Street, Liverpool This paper describes in detail the results of transfusing autologous and allogeneic cells in ponies.
Methods
The animals used were ponies of mixed breeding, believed to be unrelated; none had previously been transfused and none of the females had foaled. Blood was taken in acid-citrate-dextrose solution and the red cells labelled with chromium-51 (Dacie & Lewis 1975) . Both the autologous and allogeneic cells were kept overnight at about 4°C before labelling, and were treated in the same way. 4-10 ml of resuspended labelled cells were injected into one external jugular vein and samples were obtained from the contralateral side. The haematocrit of each sample was measured and counts corrected to give the activity in I ml of red cells. The first sample was taken at approximately 15 minutes and subsequent results were expressed as per cent of the 15 minute activity per millilitre of red cells. In some studies external counts were made, at various times after injection, over the heart and spleen and in one animal over the liver, using a collimated scintillation counter.
Results
In Figure I , red-cell activities over about three weeks are shown in a group of animals given autologous labelled red cells; one animal was studied twice (We I and II). There was a decrease of about 20% in the first 24 hours and thereafter a less rapid fall, giving a chromium half-life of about 14 days. The true red-cell life in the horse has been shown by various cohort methods to be about 140days (Cornelius et al. 1960 , Carter et al. 1974 , and our data indicate a chromium elution rate, up to three weeks, of about 4% per day in contrast to somewhat over I%in man.
